Age, Biography and Wiki

Eric Vilain was born on 1966 in Paris, France, is an A french geneticist. Discover Eric Vilain's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 58 years old?

Popular As N/A
Occupation N/A
Age 58 years old
Zodiac Sign N/A
Born 1966
Birthday
Birthplace Paris, France
Nationality France

We recommend you to check the complete list of Famous People born on . He is a member of famous with the age 58 years old group.

Eric Vilain Height, Weight & Measurements

At 58 years old, Eric Vilain height not available right now. We will update Eric Vilain's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Eric Vilain Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Eric Vilain worth at the age of 58 years old? Eric Vilain’s income source is mostly from being a successful . He is from France. We have estimated Eric Vilain's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income

Eric Vilain Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Eric Vilain Wikipedia
Imdb

Timeline

Eric Vilain is a physician-scientist and professor in the fields of Differences of Sex Development (DSDs) and precision medicine.

He is the Associate Vice Chancellor for Scientific Affairs at the University of California, Irvine Health Affairs and also the director of the UCI Institute for Clinical and Translational Science.

He previously was the director of the Center for Genetic Medicine Research at Children's National Medical Center and the chair of the Department of Genomics and Precision Medicine at the George Washington University School of Medicine & Health Sciences in Washington, D.C. Vilain is a fellow of the American College of Medical Genetics, serves on the International Olympic Committee's Medical Commission, and sits on the Board of Scientific Counselors for the National Institute of Child Health and Human Development (NICHD).

Vilain is known for his research on the molecular mechanisms of DSDs, using DNA sequencing and animal models to discover the biological bases of sex differentiation.

In addition to DSDs, Vilain has also published a large body of research on sex differences in the brain, the biology of sexual orientation, and gender identity.

Vilain is described as "one of the world's foremost experts on the genetic determinants of DSDs" in the journal Nature.

1966

Vilain was born in 1966, in Paris, France.

1983

He attended the Faculté de Médecine Necker Enfants Malades in 1983, and obtained his MD in 1989.

His first rotation as a medical student was in the referral center for the intersex newborns, which, he notes, was what first drove him to research DSDs.

1990

In 1990, Vilain attended the Pasteur Institute at the Université Pierre et Marie Curie and obtained his PhD in genetics in 1994.

1995

Vilain then moved to Los Angeles, California in 1995 to complete his residency and to train as a postdoctoral research fellow of Medical Genetics at the University of California, Los Angeles.

1998

In 1998, Vilain became a professor of Human Genetics and Pediatrics at the UCLA School of Medicine, and served as the Chief of Medical Genetics at the Department of Pediatrics and the Department of Urology until 2017.

1999

In 1999, Vilain was the first geneticist to describe IMAGe syndrome, a rare and severe congenital disease, and in 2012, identified its causative mutations.

2005

In 2005, he was one of the pediatricians present at the International Consensus Conference on Intersex in Chicago, to advocate for the term "disorders of sex development."

He also worked with intersex advocate Bo Laurent to remove the term "hermaphrodite" from the medical vocabulary.

2006

In August 2006, Vilain, along with other members of pediatric societies signed the Consensus statement on management of intersex disorders, which stated that "terms such as intersex, pseudohermaphroditism, hermaphroditism, sex reversal, and gender based diagnostic labels are particularly controversial."

In 2006, his team, along with geneticist Dean Hamer, published research studying the linkage of gay males and markers on their mothers' X chromosome.

2007

Vilain would write in a 2007 article for Nature Genetics titled "We Used to Call Them Hermaphrodites," that terms such as "intersex" and "hermaphrodite" should be abandoned, due to their connotations.

Vilain is currently one of the principal investigators of the Differences/Disorders of Sex Development Translational Research Network (DSD-TRN), a large research network of 10 different medical sites.

2011

In 2011, Vilain was one of the members of the International Olympic Committee Medical Commission and helped revise the policies on female athletes with DSDs such as androgen insensitivity syndrome (AIS), spurred by the case of South African runner Caster Semenya in 2009.

The Medical Commission settled on a testosterone limit of 10 nanomoles per liter of blood to be able to participate in women's events.

Vilain has expressed reticence on the policy, citing the inconsistent application of the policy by the International Association of Athletic Federations.

2012

Vilain and his collaborators started the DSD-TRN in 2012 as a registry to assist in the care of patients with DSDs.

As the Chief of Medical Genetics at UCLA, Vilain helped standardize the genetic and phenotypic reporting of DSDs to assist clinicians in interpretation and diagnosis.

2014

Since 2014, Vilain has led the joint research unit between the French Centre National de la Recherche Scientifique (CNRS) called EpiDaPo (Epigenetics, Data, Politics), an interdisciplinary research unit which studies the societal effects of genetics, environment, and big data research.

2015

During the 2015 conference of the American Society of Human Genetics, his team presented findings on potential epigenetic differences in identical male twins discordant in sexual orientation.

Researchers, however, noted and criticized the small sample size and questioned the statistical power of the study.

2017

Vilain left UCLA in 2017 to become the director of the Center for Genetic Medicine Research at Children's National Medical Center and the chair of the Department of Genomics and Precision Medicine at the George Washington University School of Medicine and Health Sciences.

In 2022 Vilain became the Associate Vice Chancellor for Scientific Affairs at University of California, Irvine.

Vilain is an expert on the Disorders of Sex Development and has published widely on the genetic pathways and molecular mechanisms underlying human sexual development.

His early research focused on the gene SRY and its role in the formation of the testes, as well as how certain mutations could explain diseases such as gonadal dysgenesis.

During his time at UCLA, he created mouse models to observe the effects of mutations on genes linked to sexual development.

2018

Vilain has been conducting global health research in the Democratic Republic of the Congo since 2018, mainly focusing on infectious diseases such as Ebola and genetic factors influencing diet-induced neurodegenerative diseases.

2019

In 2019, Vilain served as an expert witness defending Caster Semenya's right to compete as a woman in athletic competitions.

Vilain also researches sex differences in the brain, most notably the biology of gender identity and sexual orientation.

Along with other collaborators, Vilain and his team have published papers on the expression of sex-regulating genes effecting the differentiation of brains using mouse models and studied the role the SRY gene plays in regulating adult brain function.